Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease

HIV Medicine

Volumn 1, Issue 1, 1999, Pages 10-18

  Fox, P A ^a   Barton, S E ^b   Francis, N ^c   Youle, M ^a   Henderson, D C ^d   Pillay, D ^e   Johnson, M A ^a   Fearfield, L ^a   Gazzard, B G ^b   Bunker, C B ^c  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^e University of Birmingham Medical School ^*

Author keywords

Antiviral therapy, dermatology; HAART; Histopathology; HSV

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CHRONIC DISEASE; GENITAL HERPES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; MALE; PATHOLOGY; PENIS; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE REPORT; CHRONIC DISEASE; HERPES GENITALIS; HUMAN; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGE; PENIS; TREATMENT OUTCOME;

EID: 18044402185     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.1999.00003.x     Document Type: Article

References (18)

1. Bagdades EK, Pillay D, Squire SB, O'Neil C, Johnson MA, Griffiths PD. Relationship between herpes simplex virus ulceration and CD4 cell counts in patients with HIV infection. AIDS 1992; 6: 1317-1320.
2. Siegal FP, Lopez C, Hammer GS, eraJ. Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305: 1439-1444.
3. Gazzard BG, Barton SE. Therapy for herpes simplex virus with emphasis on the role of foscarnet. Curr Opin Infect Dis 1993; 6: 773-777.
4. Straus SE, Smith HA, Brickman C, DeMiranda P, McLaren C, Keeney RE. Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med 1982; 96: 270-277.
5. Huff JC, Krueger GG, Overall JC Jr, Copeland J, Spruance SL. The histopathologic evolution of recurrent herpes simplex labialis. J Am Acad Dermatol 1981; 5: 550-557.
6. Bevilacqua F, Marcello A, Toni M, er al. Acyclovir resistance/ susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. J AIDS 1991; 4: 967-969.
7. Collins P, Appleyard GA, Oliver NM. Sensitivity of herpesvirus isolates from aciclovir clinical trials. A m JMed 1982; 73:380-383.
8. Krausa P, Young D, Gotch F. Identification of a new HLA-A allele (A*2502) by PCR-SSP. Immunogenetics 1996; 45: 84-85.
9. Henderson DC, Rippin JJ. Stimulus dependent production of cytokines and pterins by peripheral blood mononuclear cells. Immunol Lett 1995; 45: 24-29.
10. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 1985; 75: 226-233.
11. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet and vidarabine for aciclovir resistant mucocutaneous herpes simplex in the Acquired Immunodeficiency Syndrome. N EnglJ Med 1991; 325: 551-555.
12. Karavellas MP, Lowder CY, Macdonald C, Avila CP, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalinol 1998; 116: 169-175.
13. Aldeen T, Hay P, Davidson F, Lau R. Herpes zoster infection in HIV seropositive patients associated with highly active antiretroviral therapy. AIDS 1998; 12: 1719-1720.
14. French M, Lenzo N, John M, eraJ. Immune restoration disease after treatment of immunodeficient HIV infected patients with potent antiretroviral therapy. 12th World AIDS Conference. Geneva (Abstract 340/22323), 1998.
15. Rinaldo CR, Torpcy DJ. Cell mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency 1993; 5: 33-90.
16. Howell DM, Feldman M, Siegal FP, Pettera L, FitzgeraldBocarsly P. Peripheral blood of AIDS patients contains cells capable of providing accessory function for the natural killer cell mediated, lysis of herpes simplex virus infected targets despite low Interferon alpha production. J AIDS 1993; 6: 15-23.
17. Peakman M, Vergani D. Basic and Clinical Immunology. Chapter 7. Cellular immune responses: T lymphocytes, antigen presentation and natural killers. Churchill Livingstone, Edinburgh, 1997.
18. Lalezari J, Schaker T, Feinberg J, et al. A randomised, double-blind, placebo controlled trial of cidofovir gel for the treatment of acyclovir unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis 1997; 176: 892-898.